Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (321-330 of 706) with videos related to

Pageof 71
Sort By:
Journal of the American Heart Association|October 30, 2018
Average Clinician-Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE TrialWilliam B White, Fatima Jalil, William C Cushman, et al.
Chest|July 24, 2008
Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Robert A Harrington, Richard C Becker, Christopher P Cannon, et al.
European Heart Journal|August 30, 2016
The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trialAlon Eisen, Christopher P Cannon, Michael A Blazing, et al.
The American Journal of Cardiology|April 5, 2020
Contemporary Trends in Prescription of Dipeptidyl Peptidase-4 Inhibitors in the Context of US Food and Drug Administration Warnings of Heart Failure RiskMuthiah Vaduganathan, Avinainder Singh, Abhinav Sharma, et al.
Journal of Thrombosis and Thrombolysis|July 13, 2007
Angiographic perfusion score in patients treated with PCI at late angiography following fibrinolytic administration for ST-segment elevation myocardial infarction is associated with morbidity and mortality at 30 daysYuri B Pride, Jacqueline L Buros, Erin Lord, et al.
American Heart Journal|April 1, 2009
Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trialQuynh A Truong, Christopher P Cannon, Neil A Zakai, et al.
Circulation|August 31, 2011
Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trialMatthew J Price, Dominick J Angiolillo, Paul S Teirstein, et al.
The New England Journal of Medicine|August 30, 2017
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease, Louise Bowman, Jemma C Hopewell, et al.
Journal of the American Heart Association|May 22, 2016
Multimarker Risk Stratification in Patients With Acute Myocardial InfarctionMichelle L O'Donoghue, David A Morrow, Christopher P Cannon, et al.
Clinical Cardiology|May 20, 2008
Assessing the current role of platelet function testingEugene Braunwald, Dominick Angiolillo, Eric Bates, et al.
Pageof 71

Showing results (321-330 of 706) with videos related to

Sort By:
Pageof 71
Journal of the American Heart Association|October 30, 2018
Average Clinician-Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE TrialWilliam B White, Fatima Jalil, William C Cushman, et al.
Chest|July 24, 2008
Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Robert A Harrington, Richard C Becker, Christopher P Cannon, et al.
European Heart Journal|August 30, 2016
The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trialAlon Eisen, Christopher P Cannon, Michael A Blazing, et al.
The American Journal of Cardiology|April 5, 2020
Contemporary Trends in Prescription of Dipeptidyl Peptidase-4 Inhibitors in the Context of US Food and Drug Administration Warnings of Heart Failure RiskMuthiah Vaduganathan, Avinainder Singh, Abhinav Sharma, et al.
Journal of Thrombosis and Thrombolysis|July 13, 2007
Angiographic perfusion score in patients treated with PCI at late angiography following fibrinolytic administration for ST-segment elevation myocardial infarction is associated with morbidity and mortality at 30 daysYuri B Pride, Jacqueline L Buros, Erin Lord, et al.
American Heart Journal|April 1, 2009
Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trialQuynh A Truong, Christopher P Cannon, Neil A Zakai, et al.
Circulation|August 31, 2011
Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trialMatthew J Price, Dominick J Angiolillo, Paul S Teirstein, et al.
The New England Journal of Medicine|August 30, 2017
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease, Louise Bowman, Jemma C Hopewell, et al.
Journal of the American Heart Association|May 22, 2016
Multimarker Risk Stratification in Patients With Acute Myocardial InfarctionMichelle L O'Donoghue, David A Morrow, Christopher P Cannon, et al.
Clinical Cardiology|May 20, 2008
Assessing the current role of platelet function testingEugene Braunwald, Dominick Angiolillo, Eric Bates, et al.
Pageof 71